Arya Moftakhar, S. E. Khoshnam, Maryam Farzaneh, Mahrokh Abouali Gale Dari
{"title":"Functional Roles of Long Non-coding RNAs on Stem Cell-related Pathways in Glioblastoma","authors":"Arya Moftakhar, S. E. Khoshnam, Maryam Farzaneh, Mahrokh Abouali Gale Dari","doi":"10.2174/0115743624311471240703071345","DOIUrl":null,"url":null,"abstract":"\n\nLong non-coding RNAs (lncRNAs), characterized by their length exceeding 200 nucleotides\nand lack of protein-coding capacity, are intricately associated with a wide array of cellular\nprocesses, encompassing cell invasion, differentiation, proliferation, migration, apoptosis,\nand regeneration. Perturbations in lncRNA expression have been observed in numerous diseases\nand have emerged as pivotal players in the pathogenesis of diverse tumor types. Glioblastoma, a\nhighly malignant primary tumor of the central nervous system (CNS), remains a formidable\nchallenge even with the advent of novel therapeutic interventions, as primary glioblastomas invariably\nexhibit therapy resistance and aggressive behavior. Glioblastomas can arise from progenitor\ncells or neuroglial stem cells, revealing profound cellular heterogeneity, notably in the\nform of glioblastoma stem cells (GSCs) possessing stem-like properties. Glioblastomas comprise\nneural precursors that harbor essential characteristics of neural stem cells (NSCs). Several\nsignaling pathways have been implicated in the regulation of self-renewal in both cancer cells\nand stem cells. In addition to their involvement in therapy resistance and survival of glioblastoma,\nlncRNAs are implicated in the modulation of GSC behaviors through diverse pathways and\nthe intricate regulation of various genes and proteins. This review aims to comprehensively discuss\nthe interplay between lncRNAs, their associated pathways, and GSCs, shedding light on\ntheir potential implications in glioblastoma.\n","PeriodicalId":10868,"journal":{"name":"Current Signal Transduction Therapy","volume":"83 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Signal Transduction Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115743624311471240703071345","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Long non-coding RNAs (lncRNAs), characterized by their length exceeding 200 nucleotides
and lack of protein-coding capacity, are intricately associated with a wide array of cellular
processes, encompassing cell invasion, differentiation, proliferation, migration, apoptosis,
and regeneration. Perturbations in lncRNA expression have been observed in numerous diseases
and have emerged as pivotal players in the pathogenesis of diverse tumor types. Glioblastoma, a
highly malignant primary tumor of the central nervous system (CNS), remains a formidable
challenge even with the advent of novel therapeutic interventions, as primary glioblastomas invariably
exhibit therapy resistance and aggressive behavior. Glioblastomas can arise from progenitor
cells or neuroglial stem cells, revealing profound cellular heterogeneity, notably in the
form of glioblastoma stem cells (GSCs) possessing stem-like properties. Glioblastomas comprise
neural precursors that harbor essential characteristics of neural stem cells (NSCs). Several
signaling pathways have been implicated in the regulation of self-renewal in both cancer cells
and stem cells. In addition to their involvement in therapy resistance and survival of glioblastoma,
lncRNAs are implicated in the modulation of GSC behaviors through diverse pathways and
the intricate regulation of various genes and proteins. This review aims to comprehensively discuss
the interplay between lncRNAs, their associated pathways, and GSCs, shedding light on
their potential implications in glioblastoma.
期刊介绍:
In recent years a breakthrough has occurred in our understanding of the molecular pathomechanisms of human diseases whereby most of our diseases are related to intra and intercellular communication disorders. The concept of signal transduction therapy has got into the front line of modern drug research, and a multidisciplinary approach is being used to identify and treat signaling disorders.
The journal publishes timely in-depth reviews, research article and drug clinical trial studies in the field of signal transduction therapy. Thematic issues are also published to cover selected areas of signal transduction therapy. Coverage of the field includes genomics, proteomics, medicinal chemistry and the relevant diseases involved in signaling e.g. cancer, neurodegenerative and inflammatory diseases. Current Signal Transduction Therapy is an essential journal for all involved in drug design and discovery.